Coumestrol is a naturally occurring plant coumarin that displays high affinity for the hormone-binding site of the human estrogen receptor (hER), for which it serves as a potent non-steroidal agonist. Coumestrol emits intense blue fluorescence when bound to this protein, making it ideally suited for use as a cytological stain to detect ER in fixed and intact cells, Conditions are reported for the efficient detection of recombinant ER protein artifcially e x p d in cultured c e b by calcium phosphate-mediated transfection. Coumestrol fluorescence co-localizes with hER protein detected by indirect immunofluorescence with an hER-specific anti-peptide antiserum, confirming the specificity of this reagent. Fluorescene from ER occupied by coumestrol shows a predominantly nuclear distribution, even when the receptor protein is cross-
Introduction
The subcellular distribution of steroid receptors remains a question of considerable interest and controversy. Early studies based on fractionation of cell lysates prepared from tissues responsive to estrogen indicated that the majority of [3H]-estradioLbinding activity can be recovered in the cytosol of untreated cells, but higher salt concentrations are required to extract the receptor from the nuclear fraction of cells treated with hormone (1.2) . By analogy to similar observations made with other members of the steroid receptor family, such behavior supported the generalization that hormone-dependent translocation of steroid receptors from the cytoplasm to the cell nucleus is a crucial step in the mechanism of steroid action. This model has been substantially revised for most members of the nuclear receptor superfamily since the revelation that these receptors are almost exclusively localized to the nucleus, even in cells that have been withdrawn from hormone, as evidenced by a variety of biochemical and immunocytochemical techniques. Patterns of localization that are predominantly nuclear have been amply documented for the estrogen receptor (ER) (3-5) and the progesterone receptor (5-8). Conflicting reports exist for the subcellular distribution of the glucocorticoid receptor (8) (9) (10) (11) (12) (13) (14) (15) 11794-8651. linked in situ by fixation with glutaraldehyde plus paraformaldehyde before coumestrol exposure. This corroborates previous conclusions, based on indirect immunofluorescenc-e analysis, that the ER remains nuclear in the absence of hormone. Examination of the pattern of coumestrol staining in mitotic ceb further indicates that hER remains associated with condensed chromatin. Such observations illustrate the potential for using coumestrol to investigate real-time effects of a variety of physiological stimuli on the subcellular distribution of hER in living cells. (JHisrochem Cyrochem KEY WORDS: Coumestrol; Estrogen receptor; Fluorescence microscopy; Non-steroidal estrogen; Nuclear localization; Phytoestrogen; Steroid receptors; Transfection.
41:801-810, 1993)
androgen receptor (16J7). In the case of the mineralocorticoid receptor, existing evidence suggests a subcellular distribution similar to that of the closely related glucocorticoid receptor (18,19). Growing evidence exists that the distribution of a steroid receptor between the cytoplasm and nucleus should be regarded as a dynamic rather than a static phenomenon. Similar to that of other nuclear proteins, synthesis of the ER is presumed to occur on cytoplasmic ribosomes, requiring at least brief residence of this protein within the cytoplasmic compartment before it gains entry into the nucleus through nuclear pore complexes in an energy-requiring process. Guiochon-Mantel and colleagues (20) have examined the effect of energy depletion on the subcellular distribution of the progesterone and estrogen receptors. Observing a dramatic loss of immunohistochemically detectable receptor from the nucleus after treatment of receptor-expressing cells with inhibitors of ATP synthesis, the authors conclude that accumulation of these receptors within the nuclear compartment reflects a dynamic steady state determined by active transport into the nucleus opposed by passive efflux from the nucleus. Constant shuttling of receptors between the cell cytoplasm and the nucleus raises the possibility that transit of the steroid receptors through the cytoplasmic compartment may be an obligatory step in the process of receptor recycling or reactivation after withdrawal of the hormonal stimulus.
The visualization of a dynamic process such as nuclear translocation ideally requires a protocol that avoids the use of cell fixatives and permeabilizing agents and that can be adapted for use in living cells. One such technique involves the staining of steroid receptors in cells in situ with the use of fluorescent ligands. A variety of fluorescent probes have been developed for the ER, most commonly involving the derivatization of 17-P-estradiol with a fluorophore (21) (22) (23) (24) (25) (26) . Such an approach, however, frequently results in a bulky ligand with substantially reduced affinity for the ER or poor uptake by cells, limiting their usefulness for physiological studies in whole cells. Coumestrol, a naturally occurring phytoestrogen that displays both high affinity and intense blue fluorescence when bound to the estrogen receptor (21), circumvents many of these problems. This study was undertaken to examine the suitability of coumestrol for use as a specific fluorescent probe to analyze the subcellular distribution of ER in living cells.
Materials and Methods
Reagents and Antibodies. Coumesuol (purified by acetylation, recrystallization, and vacuum sublimation) was generously provided by Dr. Angelo Notides (University of Rochester, NY). It is also available from Indofine Fine Chemicals (Piscataway, NJ). Phenol red-free Dulbecco's modified Eagle's medium (DMEM) was obtained from Gibco (Grand Island, NY). Hormone, chemicals, and calf serum for cell culture were purchased from Sigma (St Louis, MO). SB107 represents a polyclonal anti-ER antiserum raised against a synthetic peptide corresponding to amino acid residues 34-48 of the hER. SB107 interacts with both native and denatured ER and specifically recognizes a 67 KD protein on immunoblots, consistent with the size of full-length ER. Control indirect immunofluorescence experiments show that pre-immune SB107 serum gives undetectable staining of COS-7 cells transiently expressing ER and that SB107 immune serum fails to stain COS-7 cells that do not express ER (R. Miksicek, data not shown). Affinity-purified, rhodamine-conjugated goat anti-rabbit IgG F(ab)2 fraction was from Boehringer Mannheim (Indianapolis, IN).
Cell Culture and Transfection. Cell lines used for this study were routinely maintained in phenol red-free DMEM containing 10% (vlv) calf serum and supplemented with 5 mM HEPES (pH 7.4), 2 mM glutamine, penicillin (50 Ulml), and streptomycin (50 pglml). For transient transfection assays to investigate the hormonal properties of coumestrol, approximately 2 x lo6 HeLa cells were co-transfected with 16 pg of pERE-TK-CAT (27) and 1 pg of pER18 and analyzed as previously described (28) . For ER staining, 1 x lo6 cos-7 cells were transfected with 10 pg of pCMV-4 (29), pCMV-ER (Wang and Miksicek, unpublished observations) , or pCMVanti-ER (Miksicek, unpublished observations), using standard Cap04 coprecipitation methods (30) , followed by a 3-min treatment with DMEM containing 15 % (vlv) glycerol to improve transfection efficiency. Twentyfour hours later, transfected cells were passaged by trypsinization and plated in 100-mm dishes containing sterilized No. 1 coverslips in media containing 5% (vlv) charcoal-treated calf serum, with or without added steroids as indicated. Staining for ER was performed as described below.
Competitive Binding Assay. To determine the ability of expressed recombinant hER to bind coumestrol, cos-7 cells were transfected as described above with 10 pg of pCMV-ER. Two days after transfection, cells were harvested by scraping and were sonicated in extraction buffer [0.4 M KCI, 20 mM Pis-HC1, pH 7.4, 1 mM EDTA, 2 mM D' IT, 10 mM sodium molybdate, 10% (vlv) glycerol] which was supplemented to a final concentration of 1 pglml of each of four protease inhibitors (aprotinin, leupeptin, pepstatin, and chymostatin). Post-mitochondrial supernatants were prepared from the sonic extracts by centrifugation at 45,000 rpm for 60 min at 4'C in a Ti75 rotor (Beckman Instruments). Estradiol-binding activity was determined using [2,4,6,7,16,17(N)]-3H-17-P-estradiol 170 Cilmmol (New England Nuclear; Boston, MA) after the method of Scatchard (31) and was consistently in the range of 1-5 pmollmg protein, with an equilibrium binding constant (&) of 0.3-1.2 nM. The binding affinity of coumestrol relative to 17-P-estradiol was determined by incubating 100 pg of protein from extracts of pCMV-ER-transfected cos-7 cells with [3H]-17-P-estradiol (10 nM) in the presence of increasing concentrations of competitor for 2 hr at room temperature. Bound hormone was determined as radioactivity resistant to adsorption by dextran-coated charcoal (32) .
Coumestrol Staining, Fixation, and Indirect Immunofluorescence. Expression and distribution of ER were assessed by incubating coverslips containing transfected cos-7 cells in medium supplemented with coumestrol to a final concentration of lo-* or lo-' M, as indicated. Transfected cells used for double staining with coumestrol in combination with anti-ER antibodies were fixed for 3 min in PBS 2 % (wlv) with respect to paraformaldehyde, permeabilized by treatment with 0.20/0 (vlv) Triton X-100, and incubated in the presence of a 1:500 dilution of the SB107 anti-peptide antiserum (in Tris-buffered saline) for 30 min at 37°C in a humidified chamber. Bound antibody was detected by staining with a 1:4000 dilution of rhodamine-conjugated goat anti-rabbit IgG F(ab), fragment in Trisbuffered saline containing IO-' M coumestrol for 30 min at 37°C in a humidified chamber. Samples were analyzed with a Ziss Axiophot epifluorescence photomicroscope using a x 40 objective lens.
Coumestrol Binds to and Activates the Human Estrogen Receptor
Coumestrol is one of a variety of naturally occurring plant estrogens found in forage crops (33) . It exhibits bright blue fluorescence with an emission maximum at 438 nm when excited at 376 nm (34) at neutral or acidic pH. When bound to the ER, fluorescence emitted by coumestrol increases in intensity and shows a shift to 410 nm, indicative of the hydrophobic character of the ligandbinding site (21). These properties make coumestrol uniquely suited among ligands of the ER for use as a fluorescent probe to investigate the receptorlligand interaction and the cell biology of this hormone-regulated transcription factor.
To reconfirm that coumestrol acts as a hormonal agonist when bound to the hER, transient transfection experiments were performed to express an hER cDNA in cells in culture. The hormonelike activity of coumestrol was examined in a dose-response curve in which both the receptor protein (expressed from the plasmid PER) and an estrogen-responsive reporter gene (pERE-TK-CAT) were co-transfected into HeLa cells. As indicated in Figure 1A , increasing concentrations of coumestrol resulted in a progressive increase in the amount of CAT enzyme expressed from the reporter plasmid, with a half-maximal response at M. Therefore, coumestrol is less potent than the natural ligand, 17-P-estradio1, which shows a half-maximal response near lo-" M, although both agonists induce gene expression to the same maximal extent. This difference in estrogenic activity is reflected to some extent in the higher affinity of the ER or 17-o-estradiol compared with coumestroi, as judged from their relative ability to compete with [ 3H]-17-Pestradiol for binding to the receptor ( Figure 1B) . The remarkable potency of 17-P-estradiol vs coumestrol in vivo illustrates the paradoxical ability of estradiol, but not coumestrol, to induce a transcriptional response in cell culture at a concentration well below its apparent a for binding to hER. These data imply that binding of coumestrol to hER in vivo should saturate between lo-' and M and that, when bound, coumestrol should place this receptor in its active, or transformed, conformation.
Coumestrol Staining of Estrogen Receptors
For a fluorescent ligand to be suitable as a cytological probe for detection of its receptor in cultured cells, it must fulfill several requirements. Binding specificity for the target receptor must be high, to minimize the level of background staining caused by spurious binding reactions. The quantum yield of fluorescence must also be sufficiently high to permit detection of its target protein at physiological concentrations. The probe must also show fluorescence emission at a wavelength where minimal interference is contributed by the autofluorescence of other cell components. Finally, to generate an acceptable signal-to-noise ratio, either the probe must show a significant increase in fluorescence yield on binding to its receptor or convenient methods must be available for the removal of unbound fluorescent probe.
To determine if coumestrol satisfies these criteria for fluorescent detection of ER in cultured cells, Cos-7 cells, which were induced to express the hER protein by transient transfection with an hER cDNA expression plasmid, were cultured on coverslips and incubated for 2 hr at 37'C in cell culture medium (DMEM, 5% charcoal-treated calf serum) containing a final concentration of lo-' M coumestrol. The coverslips were then examined in the presence of coumestrol-containing medium without fixation or further treatment. Under these conditions, 5-1096 of the cells typically take up and express the hER cDNA and demonstrate a pattern of intense blue nuclear fluorescence. In interphase cells, nuclear fluorescence is non-uniform (either granular or punctate in appearance) and is usually but is not invariably excluded from the nucleoli (Figures 2A and 6 ). This staining is specific for the ER, as it is not observed in cells transfected with a series of control plasmids. These include the parental expression vector lacking a cDNA insert (pCMV4; data not shown), a pCMV4 derivative in which the hER cDNA is inserted in an anti-sense orientation (pCMV-anti-ER, Figure 2B ), or pCMv4 that expresses a rat glucocorticoid receptor cDNA (pCMV-rGR data not shown). Furthermore, binding of coumestrol to the ligand-binding site of the ER is necessary for the observed pattern of fluorescence, since nuclear staining is sensitive to competition by an excess of either 17-P-estradiol or diethylstilbestrol ( Figures 2C and 2D, respectively) . Diffuse cytoplasmic fluorescence can be observed in cells transfected with control plasmids lacking an ER cDNA, but this background fluorescence is insensitive to competition by 17-P-estradiol. This indicates that the low level of ubiquitous cytoplasmic staining observed in cells that lack nuclear fluorescence is unrelated to the presence of the ER.
Staining of ER-containing cells with coumestrol is optimal using lo-* to M ligand and the staining intensity reaches saturation within 10 min after exposure to coumestrol at room temperature or 37°C. Coumestrol staining can be routinely performed without fixation or permeabilization, although cross-linking fixatives such as glutaraldehyde and paraformaldehyde [treatment with a 3% (v/v) paraformaldehyde, 0.5% (dv) glutaraldehyde solution for 2-5 min at room temperature] do not appreciably reduce the efficiency of coumestrol staining. Preparations can be mounted and observed in the presence of lo-' M coumestrol or washed and mounted in buffered saline, as preferred, without increasing background fluorescence or reducing the fluorescence signal, respectively.
As a further indication that the nuclear fluorescence observed after coumestrol treatment of hER-expressing cells genuinely reflects the distribution of the ER, preparations were subjected to double staining with coumestrol in combination with an hER-specific antiserum. To perform indirect immunofluorescence analysis, Cos-7 cells transiently expressing the ER and cultured in the absence of hormones were first fixed with 2% (w/v) paraformaldehyde, followed by permeabilization with 0.2% (v/v) Triton X-100. Preliminary experiments confirmed that fixation of cell proteins by paraformaldehyde did not interfere with the ability of coumestrol to interact with hER and that the fixed receptor was resistant to extraction by subsequent detergent treatment. A direct correspondence was observed between cells showing coumestrol-dependent nuclear fluorescence and those which reacted with the hER-specific anti- bodies (Figure 3) . The anti-receptor antiserum chosen for these experiments was raised against a synthetic peptide derived from the amino terminus of hER, distant from the ligand-binding site of the receptor. Therefore, association of the anti-peptide antibody did not interfere with coumestrol binding and, conversely, occupation of the receptor by coumestrol was compatible with recognition of the receptor by antibody. These results convincingly argue that the nuclear protein visualized by coumestrol in pCMV-ERtransfected cos-7 cells is indeed the ER.
Staining of the Estrogen Receptor by Coumestrol Is Reversible
The agonist properties of coumestrol ( Figure 1 ) predict that it should interact with the ER in a reversible manner. Since fluorescence microscopy appears to detect only the fraction of coumestrol that is receptor bound, the observed nuclear fluorescence should be highly sensitive to dissociation of the fluorescent ligand from the receptor. To further assess this question, cos-7 cells were transfected with pCMV-ER and pre-treated with coumestrol (lo-* M) for 2 hr at 37°C. Immediately before microscopic observation, the cells were washed twice with medium lacking coumestrol and mounted in DMEM containing lo-' M diethylstilbestrol. This non-steroidal estrogen was included to prevent reassociation of coumestrol with the ER. Diethylstilbestrol has a high affinity for hER and displays no fluorescence under the conditions used to observe coumestrol. As shown in Figure 4 , fluorescence originating from the nucleus of individual cells expressing hER is lost as coumestrol bound to the receptor is displaced by diethylstilbestrol. The kinetics of coumestrol dissociation at room temperature appear to be relatively rapid, since nuclear fluorescence approaches background levels within 1-2 hr after coumestrol removal. This result also demonstrates that the interaction of coumestrol with the hER is a reversible phenomenon, suggesting that this compound has excellent 
Receptor Dbtribution in Untransformed Cells
Since coumestrol represents an active agonist for the ER, the pattern of nuclear fluorescence observed in ER-expressing cells treated with coumestrol in vivo should reflect the distribution of activated or "transformed" receptors, comparable to that seen after estradiol treatment. A modification of this staining protocol should also provide a convenient and relatively non-invasive method of assessing the subcellular localization of this receptor before activation by agonist. For this purpose, transiently transfected cos-7 cells plated on coverslips were fixed for 2 min in buffered saline containing 3% paraformaldehyde, 0.5% glutaraldehyde before and after exposure to lo-' M coumestrol for 1 hr. It was reasoned that in situ cross-linking of cellular proteins, including the ER, with aldehyde fivatives would still permit fluorescent detection of ER with coumestrol (see Figure 3 ) but would effectively prevent any redistribution of receptor from occurring as a result of its interaction with this agonist. Typical examples of cells stained under these conditions are shown in Figures >A and 5B. representing "unuansformed receptor (visualized with coumestrol after paraformaldehyde crosslinking) and "uansformed receptor (stained with coumesuol before cross-linking), respectively. Coumestrol staining remains nuclear despite in situ cross-linking of ER before exposure to this fluorescent agonist. Determining whether a redistribution of receptor occurs within the nuclear compartment after exposure of cells to agonist will require the application of higher-resolution techniques such as confocal microscopy. In agreement with observations based on immunohistochemical localization studies of this receptor in control and hormone-treated cells (3,5), the results presented here argue against a pronounced redistribution of ER in response to agonist treatment.
Significant heterogeneity can be discerned in the staining pattern displayed by cells expressing hER after treatment with coumestrol. The majority of cells show granular or reticular nuclear fluorescence, with characteristic exclusion of coumestrol from the nucleolar region and no discernible specific staining of cytoplasmic components ( Figure 6A ). Other patterns of staining observed in a minority of cells include punctate nuclear staining ( Figures   6B and 6C) , nuclear staining combined with fluorescent foci distributed randomly throughout the cytoplasm ( Figure 6D ), diffuse fluorescent staining of both the nuclear and cytoplasmic compartments ( Figure 6E) , and occasional cells with brightly stained nuclear masses ( Figure 6F ). The prevalence of each of these staining patterns in transfected Cos-7 cells is presented in Table 1 . At present, the cytological basis for this heterogeneity of coumesuol staining and the focal staining occasionally observed in both the nucleus and the cytoplasm is not understood. Coumestrol staining does, however, accurately reveal the distribution of ER within these cells, as similar patterns can be observed in preparations subjected to indirect immunofluorescence analysis (Figure 3; and unpublished observations). It is conceivable that this heterogeneity reflects a broad distribution of ER copy number within individual transfected cells or that interactions of the receptor with other cell components changes as interphase cells progress from GI through the Sand 
Association of Estrogen Receptor with Condensed Chromatin During Mitosis
Although the incidence of mitotic figures in an unsynchronized culture of cos-7 cells and the proportion of transfected cells that express the foreign receptor are not more than 10% of the total, occasional examples of ER-positive cells undergoing mitosis have been observed. Examples of such cells, representative of several stages of mitosis, are presented in Figures 7A-7D and appear to justify two generalizations. At stages of mitosis during which the nuclear envelope becomes dispersed (late prophase through anaphase), the entire cell profile becomes highlighted by diffuse, somewhat granular coumestrol staining. Superimposed on this background of cytoplasmic staining is a concentration of fluorescence originating from the nuclear region, indicative of association of ER with chromatin undergoing condensation into the metaphase chromosomes. Close association of receptor with condensed chromosomes is even 
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Non-uniform nuclear staining with nucleolar occlusion. as shown in Figure 6A . Figures 6B and 6C . Nuclear staining with bright nuclear masses. as shown in Figure 6F . more pronounced during cytokinesis ( Figure 7D ). This continued associated of receptor with chromatin is intriguing in the context of the generally accepted view that DNA is transcriptionally inactive during mitosis. At this level of analysis it is impossible to say if the association of ER with chromatin during mitosis results from a direct interaction of this DNA-binding protein with DNA or is mediated by an interaction between the receptor and non-histone chromosomal proteins.
Punctate nuclear staining. as shown in

Discussion
The spectroscopic properties of coumestrol, together with its specificity and high binding affinity for the ER, combine to make this compound uniquely suited for use as a fluorescent probe for cytological studies of this receptor. Conditions are described that enable the hER to be localized within cos-7 cells after their transfection with a mammalian expression plasmid harboring the hER cDNA. The pattern of staining observed after coumestrol treatment of ER-expressing cells is predominantly nuclear, with exclusion of the receptor from nucleoli in most cells. In addition, a minority of cells (5-20% of the total) show evidence of specific staining of receptor outside of the nuclear compartment. This usually takes the form of distinct foci distributed throughout the cytoplasm, although a more uniform, diffuse pattern of cytoplasmic staining can also be observed in some cells. It can be estimated that the equilibrium dissociation constant (Kd) of coumestrol interacting with the hER is in the range of 2-5 x 10-9 M, based on the observation that a tenfold higher molar concentration of coumestrol is required to displace [ 3H]-17-Pestradiol from hER compared with estradiol itself (Figure 1B) . Con- sistent with this estimation, the intensity of fluorescence emitted by receptor-bound coumestrol appears to saturate between and M, as does the transcriptional activity of the ER when coumestrol is used as an agonist (Figure 1A) . This behavior indicates that the use of concentrations of coumestrol in excess of M for cytological detection of hER is not only unnecessary but might adversely contribute to background fluorescence caused by loweraffinity binding of this probe to serum proteins or other cell com-
ponents.
A notable feature of this cytochemical method is the ability to directly visualize fluorescence emanating only from the fraction of coumestrol that is specifically associated with the ER, even when cells are mounted and observed in medium containing this fluorescent probe. This remarkable lack of background fluorescence coming from free coumestrol is likely to result both from a substantial increase in the fluorescence yield comparing bound with free coumestrol and from a strong blue shift in the emission spectrum of coumestrol that occurs when it occupies the hydrophobic ligandbinding pocket of the ER (21). The ability to perform microscopic observation in coumestrol-containing medium also stabilizes fluorescence intensity during longer observation periods by effectively eliminating dissociation of the probe from the receptor.
The use of coumestrol as a fluorescent probe to detect ER within cells is technically simple, rapid, and extremely flexible. It can be adapted for use in whole-cell mounts prepared with cross-linking aldehyde fixatives, although organic or other denaturing fixatives must be avoided because fluorescent staining with coumestrol requires the receptor to remain in a native conformation that can bind the ligand. More important, the negligible fluorescence originating from free coumestrol and its ability to partition into cells make this fluorescent estrogen uniquely suitable for dynamic observation of ER in living, unfixed cells. These properties of coumestrol permit a variety of novel studies, including the real-time observation of its target protein during the cell cycle, the kinetics of ligand association and dissociation in vivo, an examination of fluxes that the ER may display during normal conditions or after physiological perturbations, and a host of other new applications. Coumestrol therefore holds great promise as a tool for future investigation of the cell biology of the estrogen receptor.
